Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 3112 of 3330
Next
>>
>
77776 to 77800 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	Triciribine	AKT	AKT	1.33	uM	5895.074	0.2713	-0.3750	1.1218
184A1	NM	Basal	Triciribine	AKT	AKT	6.67	uM	5895.074	0.1873	-0.5506	1.1218
184A1	NM	Basal	Triciribine	AKT	AKT	33.3	uM	5895.074	0.0890	-0.7686	1.1218
184B5	NM	Basal	Triciribine	AKT	AKT	0.0000853	uM	5896.074	1.0117	1.0166	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.000427	uM	5896.074	0.9980	0.9972	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.00213	uM	5896.074	0.9570	0.9388	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.0107	uM	5896.074	0.8969	0.8516	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.0533	uM	5896.074	0.7436	0.6215	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.267	uM	5896.074	0.4524	0.1406	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	1.33	uM	5896.074	0.3030	-0.1413	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	6.67	uM	5896.074	0.1570	-0.4609	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	33.3	uM	5896.074	0.0802	-0.6648	1.4124
184B5	NM	Basal	Triciribine	AKT	AKT	0.0000853	uM	5897.074	0.9474	0.9174	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	0.000427	uM	5897.074	0.9657	0.9463	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	0.00213	uM	5897.074	0.9464	0.9159	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	0.0107	uM	5897.074	0.9452	0.9141	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	0.0533	uM	5897.074	0.9269	0.8850	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	0.267	uM	5897.074	0.4995	0.1640	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	1.33	uM	5897.074	0.1987	-0.4328	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	6.67	uM	5897.074	0.1492	-0.5464	1.2824
184B5	NM	Basal	Triciribine	AKT	AKT	33.3	uM	5897.074	0.0950	-0.6810	1.2824
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5898.074	0.9764	0.9342	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.000427	uM	5898.074	0.9265	0.7971	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.00213	uM	5898.074	0.9737	0.9265	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0107	uM	5898.074	0.9723	0.9227	0.7134

|<
<<
Previous
Page 3112 of 3330
Next
>>
>
77776 to 77800 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)